Civilization Ventures
Civilization Ventures is a venture capital firm focused on investing in scientific founders who are pioneering cutting-edge innovations in health tech and biology. The firm emphasizes a founder-centric approach, providing mentorship and support to help entrepreneurs reach their full potential. With a mission to back disruptive innovations that advance human longevity, Civilization Ventures manages over $100 million in capital and has partnered with more than 60 innovative companies. Their investment focus includes genomics, diagnostics, digital health, and synthetic biology.
What We Do
Civilization Ventures provides mentorship and strategic guidance to founders, leveraging their team of experienced biopharma executives and life sciences leaders to help entrepreneurs succeed.
The firm offers a unique Fellowship program to train PhDs to become entrepreneurs, fostering the growth of future life sciences founders and investors.
Civilization Ventures helps founders succeed through their vast network of industry experts, academics, and clinicians, providing access to leading innovations and resources.
Portfolio
Rocket Pharma has multiple first-in-class gene therapies in clinical trials to cure devastating inherited diseases.
#Gene Therapy
Singular Bio was acquired to help increase access to accurate genetic screening in early pregnancy.
#Genetic Screening
Lemonaid Health was acquired in a landmark $400M acquisition by 23andme.
#Telemedicine
Rewrite was acquired for $200M, marking a key move in the gene editing industry.
#Gene Editing
Foresight Diagnostics focuses on ultrasensitive diagnostics to catch cancer earlier and save lives.
#Diagnostics
BillionToOne is revolutionizing prenatal disease detection and cancer diagnostics by catching one molecule in a few billion.
#Diagnostics